Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-181-3 | CAS number: 1310-58-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
When humans are dermally exposed to low (non-irritating) concentrations, the uptake of KOH should be relatively low due to the low absorption of ions. For this reason the uptake of KOH is expected to be limited under normal handling and use conditions. Under these conditions the uptake of OH-, via exposure to KOH, is not expected to change the pH in the blood. Furthermore the uptake of potassium, via exposure to KOH, is much less than the uptake of potassium via food under these conditions. The risk of adverse effects of potassium intake from food sources is considered to be low for the general, healthy population (children and adults). The absorption of potassium is effective and about 85-90% of dietary potassium is absorbed from the gut. The potassium balance is primarily regulated by renal excretion in urine. For these reasons, KOH is not expected to be systemically available in the body under normal handling and use conditions.
Key value for chemical safety assessment
Additional information
As potassium hydroxide is dissociated in the body fluids, its systemic toxicity must be discussed for its constituting potassium and hydroxyl ions separately.
Potassium is an essential constituent of the body fluids. It is the principal intracellular cation (approximately 5.7 g/l) and it is necessary for the nervous and muscular cells function, as well as for several metabolic activities, among others the synthesis of proteins. Separation of the K+ and Na+ cations across the plasmatic membrane is assured by the ATP consuming K+/Na+ pumps, and allows membrane potentials necessary for nerve and muscle function (Marieb, 1992). Its normal plasmatic concentration is approximately 140 – 200 mg/l. The minimum toxicity level is under 250 mg/l. Between 250 and 310 mg/l, a moderate toxicity is observed, giving lassitude, fatigue and weakness. Severe toxic doses of over 310 mg/l lead to neuromuscular paralysis and, at 390-470 mg/l death from cardiac arrest, due to intraventricular conduction defects by depolarisation of cardiac muscle and subsequent increase in cardiac muscle excitability. Hyperkalemia can be produced by ingestion of 80 – 100 mg K+/kg bw, but cardiac effects predominate only after IV administration (Hazard and Safety Data Bank, Potassium Chloride, 2000).
Regulation of K+ concentration in blood is assured principally by renal excretion and reabsorption. The least increase of the K+ concentration in the extra cellular liquid stimulates strongly aldosterone liberation, which increases K+ excretion. This feedback regulation constitutes an efficient auto-regulation system (Marieb, 1992). The kidneys are able to filter approximately 24 – 27 g K+ ions daily. 90% is excreted into the urine and 10% through the faeces (Saxena, 1989).
The systemic toxicity of hydroxyl ions confounds with an elevated blood pH. The normal pH of blood is 7.35 – 7.45 and the absolute range of pH is 7.0 – 7.8. Alkalosis causes hyperactivity of the central nervous system with, above pH 7.8, tetanus, extreme excitability, convulsions and respiratory stop. Blood pH is regulated by three distinct mechanisms. An immediate mechanism is the buffering capacity of bicarbonate (approximately 1.5 g/l), proteins and in a lesser extent phosphate. A short-term mechanism is the respiration compensation. Alkalosis will be decreased by a slow and superficial respiration, a low CO2 expiration and an accumulation of HCO3- ions (higher than 1.7 g/l). A long-term mechanism is the renal compensation. Alkalosis will be decreased by an increase of the excretion of HCO3- ions (Marieb, 1992).
Interesting observations are also that alkalosis promotes renal excretion of K+, and that, for preventing hyperkalemia, extra cellular potassium is taken up by cells in exchange for hydrogen ions (Saxena, 1989). In other words, these compensating effects of K+ and OH- would attenuate the systemic effect of KOH.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.